Navigation Links
Natreon is Granted a U.S. Patent on its CROMINEX® Product
Date:3/20/2019

Natreon has been granted a U.S. Patent (10,183,047, January 22, 2019) on its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla and shilajit, that has a synergistic effect on improving lipid profile and endothelial function. This newly granted patent, along with 7 clinical studies on Crominex®3+, establish this ingredient as the ideal product for supporting heart health. This expands Natreon’s strong patent portfolio to 28 domestic and international active patents.

“We are glad that USPTO has granted a well-deserved patent for cardiovascular health benefits of Crominex®3+, the most efficacious of several chromium supplements from the market. Crominex®3+ has amazing synergistic activity that showed significant improvement in endothelial function, lipid profile, hsCRP, as well as HbA1c, which are all important factors for cardiovascular health. Synergistic activity of Crominex®3+ is achieved by using totally natural materials,” said Dr. Sanni Raju, CEO of Natreon.

Two additional clinical studies (to be published soon), show combining only 10-20 mg of Crominex®3+ (200 mcg to 400 mcg of trivalent chromium) with 2 g of fish oil (600 mg of EPA + 400 mg of DHA) enhances the health benefits of fish oil significantly.

“It is interesting to note that 10-20 mg of Crominex®3+ neither increases the size of the fish oil dosage form nor impacts the cost significantly, while enhancing fish oil’s numerous cardiovascular health benefits,” says Dr. Sanni Raju, CEO of Natreon.

About Crominex®:
Crominex®3+ is a complex of trivalent chromium (Cr3+) chloride with standardized extracts of the edible fruits of Phyllanthus emblica (amla), an Ayurvedic superfruit, and shilajit, an herbo-mineral compound from the Himalayan mountains. The polyphenolic compounds in the P. emblica extract not only contribute to a host of heart health benefits, but also help keep the Cr3+ from converting to chromium Cr6+. Furthermore, the liposomal fulvic acid in the Shilajit extract improves absorption of the complex, as it is known to enhance bioavailability of trace minerals.
With its synergistic beneficial properties, Crominex®3+ is a unique and dynamic solution for heart health and healthy aging with minimal cost. As with all Natreon ingredients, Crominex®3+ is GRAS-affirmed and non-GMO Project Verified. Visit: https://natreoninc.com/crominex-chromium-supplement/

About Natreon:
Natreon is at the forefront of nutritional ingredient innovation, quality and research. For over 20 years, Natreon has been offering scientifically validated Ayurvedic ingredients to the industry. Natreon’s extracts are purified and standardized using proprietary process technology and controls that result in optimal levels of bioactive constituents. Natreon uses sustainable sources for the raw herbs through an integrated supply chain to ensure quality and potency. Natreon has its global headquarters in New Jersey and a state-of-the-art R&D facility in Kolkata, India. For more information, visit: https://natreoninc.com/.

Contact:
Dr. Sanni Raju, CEO/Chairman or Bruce Brown, President
2-D Janine Place
New Brunswick, NJ 08901
732-296-1080

Read the full story at https://www.prweb.com/releases/natreon_is_granted_a_u_s_patent_on_its_crominex_product/prweb16180434.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. OtiTopic Granted Two Patents Covering its Dry Powder Inhaled Aspirin for the Treatment of Suspected Myocardial Infarction
2. Viora Granted New Patent for SVC Technology to Enhance Patient Experience and Ease of Application for Fractional Radiofrequency (RF) Treatments
3. FDA Clearance Granted to QT Ultrasound® for New Breast Imaging Device
4. Clinical Trial Treatment Offered at Sanford Granted FDA Approval
5. HealthyYOU Vending Granted Stipulated Judgment and Permanent Injunction Against Chris Wyland and Grow Healthy Vending in Lawsuit Settlement
6. Spinal Simplicity Announces Six New Patents Granted in 2016
7. Family Centered Treatment (FCT) Foundation Granted Continuing Education Provider Status
8. Mississippi Native Gets Wish Granted to See Atlanta Hawks Basketball Game
9. Vasont Systems Granted ISO 9001:2008 Certification for Quality Management
10. California Southern University Nursing Programs Granted Final Approval by WASC Senior College and University Commission
11. 2015 ANDI Stakeholders Meeting Concludes- Participants Welcome New Strategic Focus of ANDI, as Deserving African Institutions are Granted Innovation Awards!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... N.Y. (PRWEB) , ... April 17, 2019 , ... ... solution covering end-to-end Transaction Tracking and Application Performance Management (APM) for mission-critical applications ... and has recently introduced the latest offering, Nastel XRay® for MQ. , Nastel ...
(Date:4/16/2019)... Fla. (PRWEB) , ... April 16, 2019 , ... AdventHealth ... live with the innovative cobas® 8100 Roche automated system. AdventHealth Tampa performs more than ... laboratory team provides an industry leading turnaround time of less than 30 minutes for ...
(Date:4/16/2019)... DALLAS (PRWEB) , ... April 16, 2019 , ... Park Cities Pet Sitter has recently ... of dog walking service . Pet owners who commit to two months of ... free during that time. Park Cities Pet Sitter defines recurring dog walks as ...
(Date:4/16/2019)... , ... April 16, 2019 , ... Deciding if, when, ... want. Launching today, The Right Time initiative is making it easier for Missouri women, ... When women get pregnant on their own terms, they face fewer challenges in achieving ...
(Date:4/16/2019)... ... 16, 2019 , ... Tennant Coatings, a recognized leader in ... to introduce the new ReVue™ Hydro Polishing line for concrete floors, expanding upon ... Polishing System , including three state-of-the-art, silica-based liquids and a full line of ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ORLANDO, Fla. (PRWEB) , ... ... ... a clinical-stage biotechnology company focused on novel therapies for diseases involving mitochondrial ... Scientific Conference findings from the Phase 2/3 TAZPOWER and open-label extension (OLE) ...
(Date:4/17/2019)... MINNEAPOLIS (PRWEB) , ... April 17, 2019 , ... ... Ventas, Inc., (NYSE:VTR) and one of the nation’s largest owners and operators of ... total of 11 healthcare industry experts during the Building Owners and Managers Association ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... ... ‘Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs ... sponsors and sites alike. , Through years of experience helping sponsors manage ...
Breaking Medicine Technology: